Clinical Trial Update: A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating recombinant von Willebrand factor (rVWF) in pediatric and adult participants with severe von Willebrand disease has completed, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• recombinant von Willebrand factor (rVWF) (recombinant von Willebrand factor (rVWF))

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Von Willebrand Disease (VWD) | Phase 3 | Status: COMPLETED | Results posted: 2025-09-03